Ipswich – November 06, 2026 -- New England Biolabs (NEB) will present an integrated cfDNA and cfRNA workflow, an enzymatic DNA methylation method and a new high-fidelity PCR master mix at the Association for Molecular Pathology (AMP) Annual Meeting & Expo, held November 10-15, 2026, at the Seattle Convention Center.
NEB workshop combines Monarch purification with NEBNext library prep for multiomic profiling
The corporate workshop, "One Sample, Many Insights: Multiomic Profiling in cfDNA and cfRNA Samples," runs Wednesday, November 11, at 10:00 AM in Tahoma 3, Level 3. It pairs Monarch Nucleic Acid Purification with NEBNext NGS Library Preparation. The workflow covers extraction through sequencing, and NEB says it is designed to recover mutation, methylation and gene-expression signals from limited samples.
Nicole M. Nichols, Ph.D., NEB's Executive Director of Applications and Product Development, described cell-free nucleic acids as a "minimally invasive window into disease biology." She said realizing their potential requires workflows that extract several types of information from one sample.
Margaret R. Heider, Ph.D., and Anagha Kadam, Ph.D., both NEB Applications and Product Development Scientists III, will speak. The workshop is open to all AMP registrants. Individuals not attending the AMP meeting can register for free.
Two posters target damaged tumor samples and high-sensitivity sequencing
Heider will present both posters:
- Poster #ST176 covers NEBNext enzymatic solutions for DNA methylation profiling of highly damaged, patient-matched tumor-normal samples.
- Poster #TT065 covers a new high-fidelity PCR master mix designed for broad NGS workflow compatibility and high-sensitivity applications.
NEB says the two posters address challenging sample types and demanding molecular analysis workflows.
NEB staffs booth #922 with product development and sales teams
Members of NEB's Applications & Product Development and Sales teams will be at booth #922. Betsy Young, Ph.D., Senior Product Marketing Manager for Next Generation Sequencing, said NEB uses AMP to gather direct feedback from the molecular pathology community on workflow gaps and assay development goals.